- Home
- NRSN vs GIFT Comparison
NRSN vs GIFT Comparison
Compare NRSN & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- GIFT
- Stock Information
- Founded
- NRSN 2017
- GIFT 1999
- Country
- NRSN Israel
- GIFT United States
- Employees
- NRSN N/A
- GIFT N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- GIFT Catalog/Specialty Distribution
- Sector
- NRSN Health Care
- GIFT Consumer Discretionary
- Exchange
- NRSN Nasdaq
- GIFT Nasdaq
- Market Cap
- NRSN 31.1M
- GIFT 33.9M
- IPO Year
- NRSN 2021
- GIFT N/A
- Fundamental
- Price
- NRSN $1.22
- GIFT N/A
- Analyst Decision
- NRSN Buy
- GIFT Strong Buy
- Analyst Count
- NRSN 2
- GIFT 1
- Target Price
- NRSN $14.00
- GIFT $4.00
- AVG Volume (30 Days)
- NRSN 404.8K
- GIFT 21.9K
- Earning Date
- NRSN 09-17-2025
- GIFT 11-12-2025
- Dividend Yield
- NRSN N/A
- GIFT N/A
- EPS Growth
- NRSN N/A
- GIFT N/A
- EPS
- NRSN N/A
- GIFT N/A
- Revenue
- NRSN N/A
- GIFT $90,569,384.00
- Revenue This Year
- NRSN N/A
- GIFT $5.90
- Revenue Next Year
- NRSN N/A
- GIFT $13.45
- P/E Ratio
- NRSN N/A
- GIFT N/A
- Revenue Growth
- NRSN N/A
- GIFT 8.55
- 52 Week Low
- NRSN $0.80
- GIFT $0.82
- 52 Week High
- NRSN $2.60
- GIFT $2.38
- Technical
- Relative Strength Index (RSI)
- NRSN 44.56
- GIFT N/A
- Support Level
- NRSN $1.12
- GIFT N/A
- Resistance Level
- NRSN $1.26
- GIFT N/A
- Average True Range (ATR)
- NRSN 0.06
- GIFT 0.00
- MACD
- NRSN 0.01
- GIFT 0.00
- Stochastic Oscillator
- NRSN 36.87
- GIFT 0.00
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.